Mark M. Pomerantz

Dana-Farber Cancer Inst

$1,781,713

Attributed

$4,301,909

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY2015–25

$5M$3.8M$2.5M$1.3M$0

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$12,967,889 · 4

By mechanism

P01$8,665,980 · 1

R01$3,701,860 · 2

P50$600,049 · 1

Top collaborators

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Steven P. Balk$19,509,335
Himisha Beltran$8,786,271
Matthew Gilbert Oser$2,847,213
Matthew L Freedman$13,331,420
Dan Landau$24,446,517

Others in their field

Top investigators on “Malignant Neoplasm Of Prostate”

David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
Walter John Curran · Thomas Jefferson University$61,298,085
Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
James J. Dignam · University Of Chicago$48,310,409
Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962

Research focus

Malignant Neoplasm Of ProstateTumorProgramsMalignant NeoplasmsGenesPlayUnited StatesLocalized DiseaseResearch PersonnelDisease Natural HistoryCancer EtiologyPathway InteractionsCessation Of LifeSpecimenProstateTissuesBiopsySamplingLinkHuman TissueProtocols DocumentationDana-Farber Cancer InstituteFreezingClinically Significant